Journal Information
Scientific Letter
Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study
Evaluación del endocan para la predicción de la mortalidad en pacientes COVID-19 sometidos a ECMO veno-venosa: un estudio piloto
C. Levya,b,c,e, N. Dognona,b,c,e, S. Normandina,b,c,e, T. Duburcqa,b,c,e, A. Gaudeta,b,c,d,e,
, Lille Intensive Care COVID-19 group 1
Corresponding author
a Department of Intensive Care Medicine, Critical Care Center, CHU Lille, F-59000 Lille, France
b University of Lille, U995-LIRIC-Lille Inflammation Research International Center, Lille, France
c CHU Lille, Immunology Institute, F-59000 Lille, France
d University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Centre d’Infection et d’Immunité de Lille, F-59000 Lille, France
e University Lille, Inserm, U1285, CNRS, UMR 8576 - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France
Lille Intensive Care COVID-19 group